Cargando…
Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development
BACKGROUND: Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are responsible for a significant disease burden amongst Māori and Pacific populations in New Zealand (NZ). However, contemporary data are lacking regarding circulating group A Streptococcal (GAS) strains in NZ. Such informati...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062888/ https://www.ncbi.nlm.nih.gov/pubmed/27733129 http://dx.doi.org/10.1186/s12879-016-1891-6 |
_version_ | 1782459868336095232 |
---|---|
author | Williamson, Deborah A Smeesters, Pierre R Steer, Andrew C Morgan, Julie Davies, Mark Carter, Philip Upton, Arlo Tong, Stephen Y.C. Fraser, John Moreland, Nicole J |
author_facet | Williamson, Deborah A Smeesters, Pierre R Steer, Andrew C Morgan, Julie Davies, Mark Carter, Philip Upton, Arlo Tong, Stephen Y.C. Fraser, John Moreland, Nicole J |
author_sort | Williamson, Deborah A |
collection | PubMed |
description | BACKGROUND: Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are responsible for a significant disease burden amongst Māori and Pacific populations in New Zealand (NZ). However, contemporary data are lacking regarding circulating group A Streptococcal (GAS) strains in NZ. Such information is important in guiding vaccine development. METHODS: GAS isolates from April to June 2015 were recovered from skin and pharyngeal samples from children living in areas of high social deprivation in Auckland, NZ, a significant proportion of which are Māori or Pacific. These children are among the highest risk group for developing ARF. Isolates were compared to concurrently collected pharyngeal isolates from Dunedin, NZ, where both the proportion of Māori and Pacific children and risk of developing ARF is low. Emm typing, emm cluster typing and theoretical coverage of the 30-valent vaccine candidate were undertaken as previously described. RESULTS: A high diversity of emm types and a high proportion of emm-pattern D and cluster D4 isolates were detected amongst both skin and pharyngeal isolates in children at high risk of ARF. Pharyngeal isolates from children at low risk of ARF within the same country were significantly less diverse, less likely to be emm pattern D, and more likely to be theoretically covered by the 30-valent M protein vaccine. CONCLUSIONS: The high proportion of emm pattern D GAS strains amongst skin and pharyngeal isolates from children at high risk of ARF raises further questions about the role of skin infection in ARF pathogenesis. Emm types and emm clusters differed considerably between ARF endemic and non-endemic settings, even within the same country. This difference should be taken into account for vaccine development. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1891-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5062888 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50628882016-10-24 Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development Williamson, Deborah A Smeesters, Pierre R Steer, Andrew C Morgan, Julie Davies, Mark Carter, Philip Upton, Arlo Tong, Stephen Y.C. Fraser, John Moreland, Nicole J BMC Infect Dis Research Article BACKGROUND: Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are responsible for a significant disease burden amongst Māori and Pacific populations in New Zealand (NZ). However, contemporary data are lacking regarding circulating group A Streptococcal (GAS) strains in NZ. Such information is important in guiding vaccine development. METHODS: GAS isolates from April to June 2015 were recovered from skin and pharyngeal samples from children living in areas of high social deprivation in Auckland, NZ, a significant proportion of which are Māori or Pacific. These children are among the highest risk group for developing ARF. Isolates were compared to concurrently collected pharyngeal isolates from Dunedin, NZ, where both the proportion of Māori and Pacific children and risk of developing ARF is low. Emm typing, emm cluster typing and theoretical coverage of the 30-valent vaccine candidate were undertaken as previously described. RESULTS: A high diversity of emm types and a high proportion of emm-pattern D and cluster D4 isolates were detected amongst both skin and pharyngeal isolates in children at high risk of ARF. Pharyngeal isolates from children at low risk of ARF within the same country were significantly less diverse, less likely to be emm pattern D, and more likely to be theoretically covered by the 30-valent M protein vaccine. CONCLUSIONS: The high proportion of emm pattern D GAS strains amongst skin and pharyngeal isolates from children at high risk of ARF raises further questions about the role of skin infection in ARF pathogenesis. Emm types and emm clusters differed considerably between ARF endemic and non-endemic settings, even within the same country. This difference should be taken into account for vaccine development. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1891-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-10-12 /pmc/articles/PMC5062888/ /pubmed/27733129 http://dx.doi.org/10.1186/s12879-016-1891-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Williamson, Deborah A Smeesters, Pierre R Steer, Andrew C Morgan, Julie Davies, Mark Carter, Philip Upton, Arlo Tong, Stephen Y.C. Fraser, John Moreland, Nicole J Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development |
title | Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development |
title_full | Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development |
title_fullStr | Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development |
title_full_unstemmed | Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development |
title_short | Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development |
title_sort | comparative m-protein analysis of streptococcus pyogenes from pharyngitis and skin infections in new zealand: implications for vaccine development |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062888/ https://www.ncbi.nlm.nih.gov/pubmed/27733129 http://dx.doi.org/10.1186/s12879-016-1891-6 |
work_keys_str_mv | AT williamsondeboraha comparativemproteinanalysisofstreptococcuspyogenesfrompharyngitisandskininfectionsinnewzealandimplicationsforvaccinedevelopment AT smeesterspierrer comparativemproteinanalysisofstreptococcuspyogenesfrompharyngitisandskininfectionsinnewzealandimplicationsforvaccinedevelopment AT steerandrewc comparativemproteinanalysisofstreptococcuspyogenesfrompharyngitisandskininfectionsinnewzealandimplicationsforvaccinedevelopment AT morganjulie comparativemproteinanalysisofstreptococcuspyogenesfrompharyngitisandskininfectionsinnewzealandimplicationsforvaccinedevelopment AT daviesmark comparativemproteinanalysisofstreptococcuspyogenesfrompharyngitisandskininfectionsinnewzealandimplicationsforvaccinedevelopment AT carterphilip comparativemproteinanalysisofstreptococcuspyogenesfrompharyngitisandskininfectionsinnewzealandimplicationsforvaccinedevelopment AT uptonarlo comparativemproteinanalysisofstreptococcuspyogenesfrompharyngitisandskininfectionsinnewzealandimplicationsforvaccinedevelopment AT tongstephenyc comparativemproteinanalysisofstreptococcuspyogenesfrompharyngitisandskininfectionsinnewzealandimplicationsforvaccinedevelopment AT fraserjohn comparativemproteinanalysisofstreptococcuspyogenesfrompharyngitisandskininfectionsinnewzealandimplicationsforvaccinedevelopment AT morelandnicolej comparativemproteinanalysisofstreptococcuspyogenesfrompharyngitisandskininfectionsinnewzealandimplicationsforvaccinedevelopment |